Nihonbashi Egawa Clinic
Tokyo, Japan
Medical clinic in Chūō, Tokyo
〒103-0028 Tokyo, Chuo City, Yaesu, 1 Chome−1−3 壽ビル 2F
About Nihonbashi Egawa Clinic
"ＪＲ「東京駅」八重洲口、地下鉄銀座線・東西線「日本橋」駅から5分。内科、腎・高血圧・消化器・肝臓・整形外科・産業医。「働く人のためのクリニック」という、コンセプトのもと2001年より、身近な診療所として仕事の合間にご利用いただいております。"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Shire
5
Clinical Trials at Nihonbashi Egawa Clinic
During the past decade, Nihonbashi Egawa Clinic conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on
average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis
2017-12-05
2020-10-06
Terminated
279
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
2018-02-27
2023-12-31
Active, not recruiting
557
An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis
2018-04-04
2021-07-01
Completed
366
Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)
2018-07-17
2020-08-18
Terminated
34
Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)
2019-02-06
2021-09-13
Terminated
40
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Nihonbashi Egawa Clinic
According to Clinical.Site data, the most researched conditions in "Nihonbashi Egawa Clinic" are
"Crohn's Disease" (3 trials) and "Ulcerative Colitis" (3 trials). Many other conditions were trialed in "Nihonbashi Egawa Clinic" in a lesser frequency.
Clinical Trials Intervention Types at Nihonbashi Egawa Clinic
Most popular intervention types in "Nihonbashi Egawa Clinic" are "Drug" (4 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ontamalimab" (4 trials), "Placebo" (4 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Nihonbashi Egawa Clinic
The vast majority of trials in "Nihonbashi Egawa Clinic" are
5 trials for "All" genders.
Clinical Trials Status at Nihonbashi Egawa Clinic
Currently, there are NaN active trials in "Nihonbashi Egawa Clinic".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Nihonbashi Egawa Clinic,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Nihonbashi Egawa Clinic, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".